Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

EXPLAINER-Where are we in the COVID-19 vaccine race?

EXPLAINER-Where are we in the COVID-19 vaccine race?

BRITAIN has become the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, prioritizing the rapid deployment of the shot as it battles a major winter surge driven by a new, highly contagious variant of the virus. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has killed more than 1.7 million people worldwide: WHO IS FURTHEST ALONG? U.S. drugmaker Pfizer and German partner BioNTech are the COVID-19 vaccine trailblazers. On Nov. 18, they became the first in the world to release full…
Read More
Where are we in the COVID-19 vaccine race?

Where are we in the COVID-19 vaccine race?

PFIZER Inc and BioNTech SE has received U.S. regulatory authorization for their COVID-19 vaccine, making it the first inoculation against the new coronavirus to get a regulatory green light in the United States. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has killed 1.59 million people worldwide: WHO IS FURTHEST ALONG? U.S. drugmaker Pfizer and German partner BioNTech are the coronavirus vaccine trailblazers. On Nov. 18, they became the first in the world to release full late-stage trial data. Britain was the first to approve the shot for emergency…
Read More
Not without India: World’s pharmacy gears up for vaccine race

Not without India: World’s pharmacy gears up for vaccine race

ABHIRUP ROY, EUAN ROCHA and KRISHNA N. DAS INDIA, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders. India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer Inc and Moderna shots, the nation will play a pivotal role in immunizing much of the world. Indian companies are set to produce eight, more affordable…
Read More